{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:52:14Z","timestamp":1778777534612,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The concept of personalized therapy has been proven to be a promising approach. A popular technique is to utilize gold nanoparticles (AuNPs) as drug delivery vectors for cytotoxic drugs and small molecule inhibitors to target and eradicate oral cancer cells in vitro and in vivo. Both drug and nanocarrier designs play important roles in the treatment efficacy. In our study, we standardized the nanosystem regarding NPs type, size, surface ligands and coverage percentage leaving only the drugs mode of action as the confounding variable. We propose that similarly constructed nanoparticles (NPs) can selectively leverage different conjugated drugs irrelevant to their original mode of action. If proven, AuNPs may have a secondary role beyond bypassing cancer cell membrane and delivering their loaded drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conjugated 5- fluorouracil (5Fu), camptothecin (CPT), and a fibroblast growth factor receptor1-inhibitor (FGFR1i) to gold nanospheres (AuNSs). We followed their trajectories in Syrian hamsters with chemically induced buccal carcinomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Flow cytometry and cell cycle data shows that 5Fu- and CPT- induced a similar ratio of S-phase cell cycle arrest as nanoconjugates and in their free forms. On the other hand, FGFR1i-AuNSs induced significant sub-G1 cell population compared with its free form. Despite cell cycle dynamics variability, there was no significant difference in tumor cells\u2019 proliferation rate between CPT-, 5Fu- and FGFR1i- AuNSs treated groups. In our in vivo model, FGFR1i-AuNSs induced the highest tumor reduction rates followed by 5Fu- AuNSs. CPT-AuNSs induced significantly lower tumor reduction rates compared with the 5Fu- and FGFR1i- AuNSs despite showing similar proliferative rates in tumor cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data indicates that the cellular biological events do not predict the outcome seen in our in vivo model. Furthermore, our results suggest that AuNSs selectively enhance the therapeutic effect of small molecule inhibitors such as FGFR1i than potent anticancer drugs. Future studies are required to better understand the underlying mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07849-x","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T03:00:13Z","timestamp":1613617213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Following cytotoxic nanoconjugates from injection to halting the cell cycle machinery and its therapeutic implications in oral cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Hend M.","family":"Abdel Hamid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab E.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar M.","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada M.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa M.","family":"Donia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-7447","authenticated-orcid":false,"given":"Marwa M.","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"7849_CR1","volume-title":"Proceedings of the ASCO annual meeting 2014, Chicago, IL, USA, 30 may\u20133 June","author":"ME Davis","year":"2014","unstructured":"Davis ME. Nanoparticle delivery platform for solid tumors. In: Proceedings of the ASCO annual meeting 2014, Chicago, IL, USA, 30 may\u20133 June; 2014."},{"issue":"2","key":"7849_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/bc400271x","volume":"25","author":"MM Afifi","year":"2014","unstructured":"Afifi MM, Austin LA, Mackey MA, El-Sayed MA. XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles. Bioconjug Chem. 2014;25(2):207\u201315.","journal-title":"Bioconjug Chem"},{"issue":"2","key":"7849_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/php.12226","volume":"90","author":"MA Mackey","year":"2014","unstructured":"Mackey MA, El-Sayed MA. Chemosensitization of cancer cells via gold nanoparticle-induced cell cycle regulation. Photochem Photobiol. 2014;90(2):306\u201312.","journal-title":"Photochem Photobiol"},{"issue":"6","key":"7849_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.oooo.2012.11.020","volume":"115","author":"MM Afifi","year":"2013","unstructured":"Afifi MM, El Sheikh SM, Abdelsalam MM, Ramadan H, Omar TA, El Tantawi M, et al. Therapeutic efficacy of plasmonic photothermal nanoparticles in hamster buccal pouch carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(6):743\u201351.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"7849_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/pharmaceutics11070302","volume":"11","author":"F Ketabat","year":"2019","unstructured":"Ketabat F, Pundir M, Mohabatpour F, Lobanova L, Koutsopoulos S, Hadjiiski L, et al. Controlled drug delivery Systems for Oral Cancer Treatment-Current Status and Future Perspectives. Pharmaceutics. 2019;11(7):302.","journal-title":"Pharmaceutics."},{"issue":"3","key":"7849_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejpb.2010.11.010","volume":"77","author":"MM Jan\u00e1t-Amsbury","year":"2011","unstructured":"Jan\u00e1t-Amsbury MM, Ray A, Peterson CM, Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm. 2011;77(3):417\u201323.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"7849_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0092-8674(86)90744-0","volume":"46","author":"JW Tamkun","year":"1986","unstructured":"Tamkun JW, DeSimone DW, Fonda D, Patel RS, Buck C, Horwitz AF, et al. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell. 1986;46(2):271\u201382.","journal-title":"Cell."},{"issue":"1","key":"7849_CR8","doi-asserted-by":"publisher","first-page":"2341.41","DOI":"10.1038\/s41467-019-10112-4","volume":"10","author":"P Rees","year":"2019","unstructured":"Rees P, Wills JW, Brown MR, Barnes CM, Summers HD. The origin of heterogeneous nanoparticle uptake by cells. Nat Commun. 2019;10(1):2341.41.","journal-title":"Nat Commun"},{"key":"7849_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"D Longley","year":"2003","unstructured":"Longley D, Harkin D, Johnston P. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"7849_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","volume":"922","author":"LF Liu","year":"2000","unstructured":"Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP. Mechanism of action of camptothecin. Ann N Y Acad Sci. 2000;922:1\u201310.","journal-title":"Ann N Y Acad Sci"},{"key":"7849_CR11","first-page":"61","volume":"11","author":"B Glimelius","year":"2010","unstructured":"Glimelius B, Garmo H, Berglund \u00c5, Fredriksson LA, Berglund M, Kohnke H, et al. Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer. Pharm J. 2010;11:61.","journal-title":"Pharm J"},{"issue":"8","key":"7849_CR12","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/bjc.2013.550","volume":"109","author":"PT Nguyen","year":"2013","unstructured":"Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, Kamata N, et al. The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer. 2013;109(8):2248\u201358.","journal-title":"Br J Cancer"},{"issue":"3","key":"7849_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-013-2829-y","volume":"143","author":"T Ye","year":"2014","unstructured":"Ye T, Wei X, Yin T, Xia Y, Li D, Shao B, et al. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis. Breast Cancer Res Treat. 2014;143(3):435\u201346.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"7849_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/01926230590961845","volume":"33","author":"AP Brown","year":"2005","unstructured":"Brown AP, Courtney CL, King LM, Groom SC, Graziano MJ. Cartilage dysplasia and tissue mineralization in the rat following administration of a FGF receptor tyrosine kinase inhibitor. Toxicol Pathol. 2005;33(4):449\u201355.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"7849_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1166\/jnn.2011.3090","volume":"11","author":"D Ghosh","year":"2011","unstructured":"Ghosh D, Sarkar D, Girigoswami A, Chattopadhyay N. A fully standardized method of synthesis of gold nanoparticles of desired dimension in the range 15 nm\u201360 nm. J Nanosci Nanotechnol. 2011;11(2):1141\u20136.","journal-title":"J Nanosci Nanotechnol"},{"issue":"8","key":"7849_CR16","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1021\/nn403351z","volume":"7","author":"B Kang","year":"2013","unstructured":"Kang B, Afifi MM, Austin LA, El-Sayed MA. Exploiting the nanoparticle plasmon effect: observing drug delivery dynamics in single cells via Raman\/fluorescence imaging spectroscopy. ACS Nano. 2013;7(8):7420\u20137.","journal-title":"ACS Nano"},{"key":"7849_CR17","doi-asserted-by":"publisher","unstructured":"Bailly A, Correard F, Popov A, Tselikov G, Chaspoul F, Appay R, et al. In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-48748-3.","DOI":"10.1038\/s41598-019-48748-3"},{"key":"7849_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-4939-3603-8_29","volume":"1422","author":"S Nagini","year":"2016","unstructured":"Nagini S, Kowshik J. The hamster Buccal pouch model of Oral carcinogenesis. Methods Mol Biol. 2016;1422:341\u201350.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"7849_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3342\/ceo.2014.7.3.210","volume":"7","author":"V Faccin Bampi","year":"2014","unstructured":"Faccin Bampi V, Ferreira Vilela W, Vilela Goncalves R, Tavares Rheingantz MG, Minello LF, Braga da Silva JL, et al. The promoting effect of carbamide peroxide teeth bleaching gel in a preclinical model of head and neck cancer in hamster buccal pouch. Clin Exp Otorhinolaryngol. 2014;7(3):210\u20135.","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"22","key":"7849_CR20","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.1158\/0008-5472.CAN-09-1576","volume":"69","author":"OE Pardo","year":"2009","unstructured":"Pardo OE, Latigo J, Jeffery RE, Nye E, Poulsom R, Spencer-Dene B, et al. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res. 2009;69(22):8645\u201351.","journal-title":"Cancer Res"},{"issue":"2","key":"7849_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijpharm.2015.01.002","volume":"479","author":"KT Householder","year":"2015","unstructured":"Householder KT, DiPerna DM, Chung EP, Wohlleb GM, Dhruv HD, Berens ME, et al. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. Int J Pharm. 2015;479(2):374\u201380.","journal-title":"Int J Pharm"},{"issue":"24","key":"7849_CR22","first-page":"7280","volume":"62","author":"JL Nelson","year":"2002","unstructured":"Nelson JL, Roeder BL, Carmen JC, Roloff F, Pitt WG. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res. 2002;62(24):7280\u20133.","journal-title":"Cancer Res"},{"issue":"2","key":"7849_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0973-029X.140729","volume":"18","author":"SS Birajdar","year":"2014","unstructured":"Birajdar SS, Radhika M, Paremala K, Sudhakara M, Soumya M, Gadivan M. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2014;18(2):169\u201376.","journal-title":"J Oral Maxillofac Pathol"},{"key":"7849_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-59745-324-0_26","volume":"588","author":"GL Bratthauer","year":"2010","unstructured":"Bratthauer GL. The avidin-biotin complex (ABC) method and other avidin-biotin binding methods. Methods Mol Biol. 2010;588:257\u201370.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"7849_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/cyto.990080508","volume":"8","author":"JF Ensley","year":"1987","unstructured":"Ensley JF, Maciorowski Z, Pietraszkiewicz H, Klemic G, KuKuruga M, Sapareto S, et al. Solid tumor preparation for flow cytometry using a standard murine model. Cytometry. 1987;8(5):479\u201387.","journal-title":"Cytometry."},{"issue":"2","key":"7849_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1(2):87\u201393.","journal-title":"J Pharmacol Pharmacother"},{"key":"7849_CR27","volume-title":"Biostatistics. A foundation for analysis in the health science","author":"W Daniel","year":"1995","unstructured":"Daniel W. Biostatistics. A foundation for analysis in the health science. 6th ed. NY: John Wiley and sons, Inc; 1995.","edition":"6"},{"issue":"11","key":"7849_CR28","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1021\/jp8082425","volume":"113","author":"V Amendola","year":"2009","unstructured":"Amendola V, Meneghetti M. Size evaluation of gold nanoparticles by UV\u2212Vis spectroscopy. J Phys Chem C. 2009;113(11):4277\u201385 2009\/03\/19.","journal-title":"J Phys Chem C"},{"key":"7849_CR29","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/IJN.S21657","volume":"6","author":"XD Zhang","year":"2011","unstructured":"Zhang XD, Wu D, Shen X, Liu PX, Yang N, Zhao B, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine. 2011;6:2071\u201381.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"7849_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11671-008-9228-z","volume":"4","author":"L Sun","year":"2008","unstructured":"Sun L, Zhang Z, Wang S, Zhang J, Li H, Ren L, et al. Effect of pH on the interaction of gold nanoparticles with DNA and application in the detection of human p53 gene mutation. Nanoscale Res Lett. 2008;4(3):216\u201320.","journal-title":"Nanoscale Res Lett"},{"key":"7849_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cplett.2013.07.001","volume":"580","author":"D Dvoranov\u00e1a","year":"2013","unstructured":"Dvoranov\u00e1a D, Bobeni\u010dov\u00e1a M, \u0160oralov\u00e1ab S, Breza M. On UV\u2013Vis spectra and structure of the anticancer drug camptothecin in solutions. Chem Phys Lett. 2013;580:141\u20134.","journal-title":"Chem Phys Lett"},{"key":"7849_CR32","doi-asserted-by":"publisher","unstructured":"Essawy MM, El-Sheikh SM, Raslan HS, Ramadan HS, Kang B, Talaat IM, et al. Function of gold nanoparticles in oral cancer beyond drug delivery: implications in cell apoptosis. Oral Dis. 2020. https:\/\/doi.org\/10.1111\/odi.13551.","DOI":"10.1111\/odi.13551"},{"issue":"3","key":"7849_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bbrc.2013.03.043","volume":"434","author":"S Fujii","year":"2013","unstructured":"Fujii S, Okinaga T, Ariyoshi W, et al. Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor. Biochem Biophys Res Commun. 2013;434(3):413\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"7849_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","volume":"107","author":"W Strzalka","year":"2011","unstructured":"Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot. 2011;107(7):1127\u201340.","journal-title":"Ann Bot"},{"issue":"3","key":"7849_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311\u201322.","journal-title":"J Cell Physiol"},{"issue":"9","key":"7849_CR36","doi-asserted-by":"publisher","first-page":"16052","DOI":"10.18632\/oncotarget.14109","volume":"8","author":"YK Chae","year":"2017","unstructured":"Chae YK, Ranganath K, Hammerman PS, Vaklavas C, Mohindra N, Kalyan A, et al. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application. Oncotarget. 2017;8(9):16052\u201374.","journal-title":"Oncotarget."},{"issue":"6","key":"7849_CR37","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1021\/ac061578f","volume":"79","author":"Y Liu","year":"2007","unstructured":"Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL. Synthesis, stability, and cellular internalization of gold 36 nanoparticles containing mixed peptide-poly (ethylene glycol) monolayers. Anal Chem. 2007;79(6):2221\u20139.","journal-title":"Anal Chem"},{"key":"7849_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2010.06.004","volume":"148","author":"B Duncan","year":"2010","unstructured":"Duncan B, Kim C, Rotello VM. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release. 2010;148:122\u20137.","journal-title":"J Control Release"},{"issue":"1","key":"7849_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.18632\/oncotarget.12748","volume":"8","author":"B Redko","year":"2017","unstructured":"Redko B, Tuchinsky H, Segal T, Tobi D, Luboshits G, Ashur-Fabian O, et al. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. Oncotarget. 2017;8(1):757\u201368.","journal-title":"Oncotarget."},{"issue":"53","key":"7849_CR40","doi-asserted-by":"publisher","first-page":"55348","DOI":"10.1074\/jbc.M409230200","volume":"279","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Lin Y, Bowles C, Wang F. Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) kinase through phosphorylation-dependent release of Cks1 from FGFR substrate 2. J Biol Chem. 2004;279(53):55348\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"7849_CR41","doi-asserted-by":"publisher","first-page":"20130075","DOI":"10.1098\/rsfs.2013.0075","volume":"4","author":"C G\u00e9rard","year":"2014","unstructured":"G\u00e9rard C, Goldbeter A. The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition. Interface Focus. 2014;4(3):20130075.","journal-title":"Interface Focus"},{"issue":"5","key":"7849_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373.","journal-title":"J Cancer"},{"issue":"1","key":"7849_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-018-0816-y","volume":"17","author":"EK Kleczko","year":"2018","unstructured":"Kleczko EK, Heasley LE. Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities. Mol Cancer. 2018;17(1):60.","journal-title":"Mol Cancer"},{"issue":"1","key":"7849_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4161\/cc.5.1.2280","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang Y, Schulte BA, Zhou D. Hematopoietic stem cell senescence and long-term bone marrow injury. Cell Cycle. 2006;5(1):35\u20138.","journal-title":"Cell Cycle"},{"issue":"8","key":"7849_CR45","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","volume":"72","author":"PR Gavine","year":"2012","unstructured":"Gavine PR, Mooney L, Kilgour E, Thomas AP, Al-Kadhimi K, Beck S, et al. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res. 2012;72(8):2045\u201356.","journal-title":"Cancer Res"},{"key":"7849_CR46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21776\/ub.rjls.2015.002.01.2","volume":"2","author":"EL Gad","year":"2015","unstructured":"Gad EL, Hak H, Moawad T, Hafez G. Histological study of the effect of chemotherapy with 5-fluorouracil on Normal liver and kidney of mice. Int J Novel Res Life Sci. 2015;2:8\u201313.","journal-title":"Int J Novel Res Life Sci"},{"issue":"1638","key":"7849_CR47","doi-asserted-by":"publisher","first-page":"20130099","DOI":"10.1098\/rstb.2013.0099","volume":"369","author":"P Swietach","year":"2014","unstructured":"Swietach P, Vaughan-Jones RD, Harris AL, Hulikova A. The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc Lond Ser B Biol Sci. 2014;369(1638):20130099.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-07849-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T06:04:08Z","timestamp":1674972248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07849-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["7849"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07849-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-52128\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-52128\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-52128\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Alexandria University review committee and the procedures followed are in accordance with institutional guidelines (IRB#00010556-IORG0008839).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}